Skip to Content

Notice

Advisory Committees; Tentative Schedule of Meetings for 2011

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2011. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the Agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Teresa L. Hays, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5290, Silver Spring, MD 20993-0002, 301-796-8220.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public Start Printed Page 80060advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/​AdvisoryCommittees/​default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2011.

Table 1

Committee nameTentative date(s) of meeting(s)
OFFICE OF THE COMMISSIONER
Pediatric Advisory CommitteeMarch 21, June 21-22, December 5-6.
Risk Communication Advisory CommitteeFebruary 10-11, May 5-6, August 15-16, November 17-18.
Science Board to the Food and Drug AdministrationFebruary 25, May 20, August 19, November 10.
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory CommitteeMay 12.
Blood Products Advisory CommitteeApril 28-29, August 3-4, December 1-2.
Cellular, Tissue and Gene Therapies Advisory CommitteeFebruary 10, September 22-23.
Transmissible Spongiform Encephalopathies Advisory CommitteeDate(s), if needed, to be determined.
Vaccines and Related Biological Products Advisory CommitteeFebruary 24-25, May 18-19, September 20-21, November 16-17.
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Life Support Drugs Advisory CommitteeMarch 10.
Anti-Infective Drugs Advisory CommitteeApril date(s), if needed, to be determined.
Antiviral Drugs Advisory CommitteeApril 27-29.
Arthritis Advisory CommitteeMarch 15-16, May 3.
Cardiovascular and Renal Drugs Advisory CommitteeMarch 31, April 1, July 26-27, October 20-21, December 13-14.
Dermatologic and Ophthalmic Drugs Advisory CommitteeApril 13.
Drug Safety and Risk Management Advisory CommitteeDate(s), if needed, to be determined.
Endocrinologic and Metabolic Drugs Advisory CommitteeMarch 24.
Gastrointestinal Drugs Advisory CommitteeJanuary 12, March 8, May date(s), if needed, to be determined.
Nonprescription Drugs Advisory CommitteeFebruary 23-24.
Oncologic Drugs Advisory CommitteeFebruary 8-9, March 29-30, June 28-29, July 13-14, September 14-15, December 7-8.
Peripheral and Central Nervous System Drugs Advisory CommitteeJanuary 20-21, March 10.
Advisory Committee for Pharmaceutical Science and Clinical PharmacologyMarch 2.
Psychopharmacologic Drugs Advisory CommitteeDate(s), if needed, to be determined.
Pulmonary-Allergy Drugs Advisory CommitteeMarch 8.
Advisory Committee for Reproductive Health DrugsMarch 4, April and May date(s), if needed, to be determined.
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Medical Devices Advisory Committee (Comprised of 18 Panels)
Anesthesiology and Respiratory Therapy Devices PanelApril 15.
Circulatory System Devices PanelJanuary 25-26, February 24-25, March 24-25, April 28-29, December 8-9.
Clinical Chemistry and Clinical Toxicology Devices PanelNovember 9.
Dental Products PanelApril 12-13, September 8-9.
Ear, Nose, and Throat Devices PanelSeptember 28-29.
Gastroenterology-Urology Devices PanelJanuary 20-21, April 21-22, July 14-15, October 27-28.
General and Plastic Surgery Devices PanelFebruary 24-25, May 12-13, August 11-12, November 17-18.
General Hospital and Personal Use Devices PanelJuly 29.
Hematology and Pathology Devices PanelMarch 24-25, June 9-10, September 15-16, December 15-16.
Immunology Devices PanelMarch 31, June 30, September 29, December 1.
Medical Devices Dispute Resolution PanelApril 8.
Microbiology Devices PanelOctober 13.
Molecular and Clinical Genetics PanelMarch 3-4.
Neurological Devices PanelJanuary 27-28, March 17.
Obstetrics and Gynecology Devices PanelMay 19-20, September 22-23.
Ophthalmic Devices PanelFebruary 18.
Orthopedic and Rehabilitation Devices PanelApril 26-27, July 8.
Radiological Devices PanelJune 17, October 27-28.
National Mammography Quality Assurance Advisory CommitteeMay 6, August 9.
Technical Electronic Product Radiation Safety Standards CommitteeMay 25.
Start Printed Page 80061
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory CommitteeMarch 30-31.
CENTER FOR TOBACCO PRODUCTS
Tobacco Products Scientific Advisory CommitteeJanuary 10-11, March 17-18, May, July, September, and November date(s), if needed, to be determined.
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory CommitteeApril 11, September 12.
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
Science Advisory BoardNovember 9-10.
Start Signature

Dated: December 16, 2010.

Jill Hartzler Warner,

Acting Associate Commissioner for Special Medical Programs.

End Signature End Supplemental Information

[FR Doc. 2010-31961 Filed 12-20-10; 8:45 am]

BILLING CODE 4160-01-P